Detalhe da pesquisa
1.
A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5'-nucleotidase deficiency.
Cell Mol Biol Lett
; 27(1): 104, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434495
2.
COVID-19 therapies: do we see substantial progress?
Cell Mol Biol Lett
; 27(1): 42, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641916
3.
Identification of a Novel Mutation of ß-Spectrin in Hereditary Spherocytosis Using Whole Exome Sequencing.
Int J Mol Sci
; 22(20)2021 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34681667
4.
Efficient method for isolation of reticulocyte RNA from healthy individuals and hemolytic anaemia patients.
J Cell Mol Med
; 23(1): 487-496, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450750
5.
G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells.
Cytokine
; 116: 38-47, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30685602
6.
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A.
Blood
; 128(5): 630-7, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27330001
7.
Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.
BMC Cancer
; 18(1): 107, 2018 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29382303
8.
The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation.
Ann Noninvasive Electrocardiol
; 23(4): e12534, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363852
9.
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.
Br J Haematol
; 176(5): 783-795, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28005265
10.
MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
Eur J Haematol
; 99(5): 415-422, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805931
11.
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.
Am J Hematol
; 92(4): 359-366, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28103640
12.
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Lancet Oncol
; 17(3): 319-331, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26899778
13.
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.
Am J Hematol
; 91(9): 900-6, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222473
14.
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.
Lancet Oncol
; 16(13): 1370-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377300
15.
CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.
Blood Cells Mol Dis
; 55(4): 284-92, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460249
16.
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Am J Hematol
; 90(10): 904-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149802
17.
Azacitidine in outpatient treatment - single center experience.
Contemp Oncol (Pozn)
; 19(6): 467-70, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26843844
18.
Palmitoylation of MPP1 (membrane-palmitoylated protein 1)/p55 is crucial for lateral membrane organization in erythroid cells.
J Biol Chem
; 293(8): 2786, 2018 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475958
19.
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.
Blood
; 119(16): 3698-704, 2012 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22389254
20.
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.
Blood
; 120(18): 3670-6, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915649